stocks logo

PASG Valuation

Passage Bio Inc
$
0.298
-0.004(-1.320%)
  • Overview
  • Forecast
  • Valuation

PASG Relative Valuation

PASG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PASG is overvalued; if below, it's undervalued.

Historical Valuation

No Data

Competitors Valuation Multiple

The average P/S ratio for PASG's competitors is 1.93, providing a benchmark for relative valuation. Passage Bio Inc Corp (PASG) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

FAQ

arrow icon

Is Passage Bio Inc (PASG) currently overvalued or undervalued?

Passage Bio Inc (PASG) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 1.63. The fair price of Passage Bio Inc (PASG) is between to according to relative valuation methord.
arrow icon

What is Passage Bio Inc (PASG) fair value?

arrow icon

How does PASG's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Passage Bio Inc (PASG) as of May 19 2025?

arrow icon

What is the current FCF Yield for Passage Bio Inc (PASG) as of May 19 2025?

arrow icon

What is the current Forward P/E ratio for Passage Bio Inc (PASG) as of May 19 2025?

arrow icon

What is the current Forward P/S ratio for Passage Bio Inc (PASG) as of May 19 2025?